Arch Therapeutics Provides AC5® Commercialization Updat

FRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today

Related Keywords

United States , Canada , Terrence Norchi , Michael Abrams , Medicaid Services , Securities Exchange , Centers For Medicare , Drug Administration , Arch Therapeutics Inc , Advanced Wound , Common Procedure Coding System , Arch Therapeutics , Advanced Wound System , Topical Hemostat , Surgical Hemostat , Securities Act , Securities Exchange Act , Region ,